Bio-Rad Laboratories, Inc. Bio-Rad Laboratories, Inc.

Bio-Rad Laboratories, Inc.

BIO

Hisse Senetlerindeki Sıralama #2176
Bio-Rad Laboratories, Inc., established in 1952 and headquartered in Hercules,... Bio-Rad Laboratories, Inc., established in 1952 and headquartered in Hercules, California, operates as a global provider of life science research and clinical diagnostic products. Its operations span across the United States, Canada, Europe, Asia, and Latin America. The company is organized into two primary divisions: Life Science and Clinical Diagnostics. The Life Science division is responsible for developing, manufacturing, and commercializing a diverse array of reagents, equipment, and laboratory instruments. These products are crucial for various research methodologies, biopharmaceutical manufacturing processes, and food quality testing. This segment focuses on specialized areas within the life sciences, including proteomics, genomics, biopharmaceutical production, cellular biology, and food safety. Its clientele encompasses academic institutions (such as universities and medical schools), industrial research organizations, government agencies, pharmaceutical companies, biotechnology firms, food producers, and food testing laboratories. In contrast, the Clinical Diagnostics division designs, produces, sells, and supports a comprehensive suite of test systems, informatics solutions, diagnostic kits, and specialized quality control products for clinical laboratories. This segment provides reagents, instruments, and software specifically tailored for particular niches within the in vitro diagnostics market. Its customer base includes reference laboratories, hospital laboratories, state newborn screening facilities, physicians' office laboratories, and transfusion laboratories. Beyond these core segments, Bio-Rad also offers systems and products designed to separate complex chemical and biological materials, as well as to identify, analyze, and purify their individual components. The company distributes its extensive product portfolio through a combination of its direct sales force and a network of third-party distributors, agents, brokers, and resellers.
Hisse Fiyatı
$352.89
Son senkronizasyon: 2026-10-16
Piyasa Değeri
$9.44B
Değişim (1 gün)
-3.34%
Değişim (1 yıl)
13.83%
Ülke
US
Ticaret Bio-Rad Laboratories, Inc. (BIO)

Kategori

Healthcare
Bio-Rad Laboratories, Inc. (BIO) için Faaliyet Marjı
October 2026 itibarıyla Faaliyet Marjı TTM: 9.08%
Bio-Rad Laboratories, Inc. şirketinin en son finansal raporlarına ve hisse fiyatına göre, mevcut faaliyet marjı (TTM) 9.08%'dir. 2023 yılı sonunda şirketin faaliyet marjı 12.65% idi.
Bio-Rad Laboratories, Inc. için 2000 ile 2026 arasındaki Faaliyet Marjı geçmişi
Her yıl sonunda Faaliyet Marjı
Yıl Faaliyet Marjı Değiştir
2026 (TTM) 9.08% -13.36%
2024 10.48% -17.15%
2023 12.65% -26.54%
2022 17.22% 0.58%
2021 17.12% 3.44%
2020 16.55% 66.67%
2019 9.93% -309.49%
2018 -4.74% -187.78%
2017 5.40% 110.12%
2016 2.57% -68.89%
2015 8.26% 19.71%
2014 6.90% -13.21%
2013 7.95% -37.70%
2012 12.76% -10.33%
2011 14.23% -3.46%
2010 14.74% 13.82%
2009 12.95% 24.88%
2008 10.37% 12.11%
2007 9.25% -19.35%
2006 11.47% 17.52%
2005 9.76% -2.30%
2004 9.99% -31.25%
2003 14.53% -5.59%
2002 15.39% 12.34%
2001 13.70% 48.91%
2000 9.20% 0.00%
Benzer şirketler veya rakipler için Faaliyet Marjı
Şirket Faaliyet Marjı Faaliyet Marjı Farkı Ülke
17.03% -98.12%
US
17.86% -98.03%
IE
22.03% -97.57%
US
21.46% -97.64%
US
0.00% -
DE
Bir şirketin Faaliyet Marjı'ı nedir?
Faaliyet Marjı, bir şirketin kârlılığını değerlendirmek için temel bir göstergedir. Daha yüksek Faaliyet Marjı değerleri genellikle daha iyidir çünkü bir şirketin ürün veya hizmetlerini üretim maliyetlerinden çok daha yüksek bir fiyata satabildiğini gösterir. Faaliyet Marjı, şirketin kârının gelirine bölünmesiyle hesaplanır.